Superficial cancers cancer therapy anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells Neoplastic Stem Cells MCF-7 Cells HT29 Cells Cell Line Breast HeLa Cells Prostate

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Inbred C57BL Adenoviridae

Diseases45

Neoplasms Radiation Injuries Breast Neoplasms Colonic Neoplasms Prostatic Neoplasms Lung Neoplasms Ovarian Neoplasms Neoplasm Metastasis Stomach Neoplasms Pancreatic Neoplasms Neoplasm Invasiveness Neoplasms, Radiation-Induced Carcinoma, Squamous Cell Carcinoma Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Colorectal Neoplasms Disease Progression Cell Transformation, Neoplastic Urinary Bladder Neoplasms Adenocarcinoma Neovascularization, Pathologic Genetic Predisposition to Disease Neoplasm Recurrence, Local Head and Neck Neoplasms Neoplasms, Experimental Liver Neoplasms Rectal Neoplasms Radiation Pneumonitis Radiation Injuries, Experimental Endometrial Neoplasms Brain Neoplasms Esophageal Neoplasms Skin Neoplasms Melanoma Mammary Neoplasms, Experimental Bone Neoplasms Neoplasms, Second Primary Carcinoma, Small Cell Mouth Neoplasms Neoplasms, Hormone-Dependent Disease Models, Animal Genital Neoplasms, Female Gastrointestinal Neoplasms Thyroid Neoplasms

Chemicals and Drugs68

Antineoplastic Agents Antineoplastic Agents, Phytogenic Cisplatin Neoplasm Proteins Antibiotics, Antineoplastic Cancer Vaccines Tumor Suppressor Protein p53 Doxorubicin Paclitaxel RNA, Small Interfering Fluorouracil RNA, Messenger Drug Carriers Tumor Markers, Biological Radiation-Sensitizing Agents Camptothecin DNA, Neoplasm Receptor, erbB-2 Enzyme Inhibitors Antimetabolites, Antineoplastic Anticarcinogenic Agents Antibodies, Monoclonal Etoposide Antigens, Neoplasm Receptors, Estrogen Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Proto-Oncogene Proteins c-bcl-2 DNA-Binding Proteins Prostate-Specific Antigen Tamoxifen Tumor Suppressor Proteins P-Glycoprotein Deoxycytidine Organoplatinum Compounds Taxoids Caspases Antineoplastic Agents, Hormonal Plant Extracts Proto-Oncogene Proteins c-akt Protein-Serine-Threonine Kinases Caspase 3 Ellipticines MicroRNAs Proto-Oncogene Proteins Nuclear Proteins Prodrugs Antibodies, Monoclonal, Humanized DNA Quinazolines Apoptosis Regulatory Proteins Histone Deacetylase Inhibitors Cell Cycle Proteins Platinum Receptors, Progesterone Transcription Factors Antineoplastic Agents, Alkylating RNA, Neoplasm TOR Serine-Threonine Kinases Inhibitor of Apoptosis Proteins Vinblastine Nanocapsules Poly(ADP-ribose) Polymerases Topoisomerase I Inhibitors Reactive Oxygen Species Radiation-Protective Agents Indoles Mitomycin

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Radiation Dosage Drug Screening Assays, Antitumor Early Detection of Cancer Dose-Response Relationship, Radiation Xenograft Model Antitumor Assays Drug Delivery Systems Radiation Monitoring Combined Modality Therapy Molecular Targeted Therapy Antineoplastic Combined Chemotherapy Protocols Neoplasm Transplantation Radiotherapy Blotting, Western Reverse Transcriptase Polymerase Chain Reaction Survival Analysis Prognosis Survival Rate Transplantation, Heterologous Clinical Trials as Topic Drug Carriers Gene Expression Profiling Tumor Burden Models, Biological Retrospective Studies Follow-Up Studies Neoplasm Staging Radiotherapy Dosage Inhibitory Concentration 50 Transfection Neoplasms, Experimental Drug Design Risk Flow Cytometry Prospective Studies Disease-Free Survival Risk Assessment Chemotherapy, Adjuvant Registries Radiation Injuries, Experimental Treatment Outcome Genetic Therapy Oligonucleotide Array Sequence Analysis Radiometry Sensitivity and Specificity Drug Evaluation, Preclinical Radiotherapy, Adjuvant Gene Knockdown Techniques Mammary Neoplasms, Experimental Odds Ratio Risk Factors Immunotherapy Reproducibility of Results Kaplan-Meier Estimate Polymerase Chain Reaction SEER Program Multivariate Analysis Drug Discovery Tumor Stem Cell Assay Drug Administration Schedule Questionnaires Mammography Disease Models, Animal Immunohistochemistry Hyperthermia, Induced Individualized Medicine Nanocapsules Clinical Trials, Phase I as Topic Predictive Value of Tests Immunoenzyme Techniques Tomography, X-Ray Computed

Psychiatry and Psychology1

Phenomena and Processes54

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Drug Resistance, Neoplasm Apoptosis Cell Survival Gene Expression Regulation, Neoplastic Radiation Cell Proliferation Cell Cycle DNA Damage Dose-Response Relationship, Drug Mutation Signal Transduction Cell Division Drug Synergism Gamma Rays Down-Regulation Genetic Predisposition to Disease Inhibitory Concentration 50 Transfection Risk Cosmic Radiation DNA Repair Cell Growth Processes RNA Interference Drug Resistance, Multiple Cell Movement Time Factors Up-Regulation Phosphorylation DNA Methylation Ultraviolet Rays Sensitivity and Specificity Base Sequence Promoter Regions, Genetic Gene Silencing Cell Death Genes, p53 Odds Ratio Gene Expression Background Radiation Genotype Molecular Structure Polymorphism, Genetic Tumor Microenvironment Enzyme Activation Phenotype Genes, Tumor Suppressor Genes, BRCA1 Protein Binding Radiation Effects Genes, Neoplasm

Disciplines and Occupations7

Radiation Oncology Medical Oncology Drug Design Nanomedicine Drug Discovery Immunohistochemistry Individualized Medicine

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture3

Nanoparticles Nanomedicine Nanocapsules

Humanities1

Quality of Life

Information Science6

Survival Rate Registries Molecular Sequence Data Base Sequence SEER Program Questionnaires

Named Groups1

Health Care32

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Survival Analysis National Cancer Institute (U.S.)Survival Rate Clinical Trials as Topic Retrospective Studies Follow-Up Studies Risk Cosmic Radiation Prospective Studies Disease-Free Survival Risk Assessment Registries Radiation Injuries, Experimental Treatment Outcome Age Factors Ultraviolet Rays Sensitivity and Specificity Odds Ratio Risk Factors Reproducibility of Results Kaplan-Meier Estimate SEER Program Multivariate Analysis Questionnaires Clinical Trials, Phase I as Topic Predictive Value of Tests Radiation Effects

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Antineoplastic Agents Neoplasms Radiation Dosage Radiation, Ionizing Cell Line, Tumor Radiation Injuries Drug Screening Assays, Antitumor Early Detection of Cancer Dose-Response Relationship, Radiation Breast Neoplasms Mice, Nude Radiation Tolerance Drug Resistance, Neoplasm Apoptosis Xenograft Model Antitumor Assays Colonic Neoplasms Prostatic Neoplasms Cell Survival Lung Neoplasms Ovarian Neoplasms Gene Expression Regulation, Neoplastic Radiation Drug Delivery Systems Antineoplastic Agents, Phytogenic Cisplatin Radiation Protection Neoplasm Metastasis Stomach Neoplasms Cell Proliferation Radiation Monitoring Tumor Cells, Cultured Neoplasm Proteins Pancreatic Neoplasms Neoplasm Invasiveness Combined Modality Therapy Molecular Targeted Therapy Antibiotics, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Neoplasm Transplantation Radiotherapy Cancer Vaccines Tumor Suppressor Protein p53 Doxorubicin Cell Cycle DNA Damage Neoplasms, Radiation-Induced Carcinoma, Squamous Cell Radiation Oncology Paclitaxel RNA, Small Interfering Dose-Response Relationship, Drug Blotting, Western Reverse Transcriptase Polymerase Chain Reaction Survival Analysis Carcinoma National Cancer Institute (U.S.)Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Fluorouracil Mutation Prognosis Survival Rate Transplantation, Heterologous Clinical Trials as Topic RNA, Messenger Drug Carriers Signal Transduction Tumor Markers, Biological Radiation-Sensitizing Agents Gene Expression Profiling Colorectal Neoplasms Disease Progression Tumor Burden Cell Division Cell Transformation, Neoplastic Models, Biological Drug Synergism Urinary Bladder Neoplasms Retrospective Studies Gamma Rays Camptothecin Follow-Up Studies DNA, Neoplasm Down-Regulation Adenocarcinoma Neovascularization, Pathologic Neoplasm Staging Medical Oncology Receptor, erbB-2 Enzyme Inhibitors Radiotherapy Dosage Genetic Predisposition to Disease Survivors Neoplasm Recurrence, Local Antimetabolites, Antineoplastic HCT116 Cells Head and Neck Neoplasms Inhibitory Concentration 50 Neoplastic Stem Cells Nanoparticles

No FAQ available that match "superficial cancers cancer therapy anticancer drugs or radiation"